Rexahn Pharmaceuticals Inc (NYSE American:RNN)

1.54
Delayed Data
As of 3:59pm ET
 -0.03 / -1.91%
Today’s Change
1.42
Today|||52-Week Range
3.19
-23.76%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close1.57
Today’s open1.57
Day’s range1.53 - 1.58
Volume72,656
Average volume (3 months)321,117
Market cap$67.9M
Data as of 3:59pm ET, 06/25/2018

Growth & Valuation

Earnings growth (last year)-130.00%
Earnings growth (this year)+29.35%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.05

Competitors

 Today’s
change
Today’s
% change
SPHSSophiris Bio Inc-1.51-40.27%
EIGREiger BioPharmaceuti...-0.75-5.51%
NOVNNovan Inc-0.11-3.65%
NBYNovaBay Pharmaceutic...-0.05-1.92%
Data as of 4:10pm ET, 06/25/2018

Financials

Next reporting dateAugust 15, 2018
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$0.00
Annual profit (last year)-$25.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Peter David Suzdak
President, Chief Financial Officer &
Secretary
Douglas J. Swirsky
Corporate headquarters
Rockville, Maryland

Forecasts